Machine learning identified RDW and HGB as key predictors of hydroxyurea resistance in polycythemia vera, aiding early identification and treatment adjustment. The PV-AIM study used electronic health ...

Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The average time on hydroxyurea was 5 years, with many children on the therapy for ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Hydroxyurea conferred benefit to children and adults with hemoglobin SC disease, according to study ...

Clinical research led by Indiana University School of Medicine investigators and their collaborators in Uganda has revealed that hydroxyurea significantly reduces infections in children with sickle ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease (SCD), according to new research published in Blood ...